SCHEMBL17729329

SCHEMBL17729329

CC(=O)OCc1ccccc1C#C[Si](C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
FFAR1 O14842 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
KDM4E B2RXH2 3/20 0.38
TSHR P16473 2/20 0.37
CYP3A4 P08684 2/20 0.37
KMT2A Q03164 3/20 0.37
MAPT P10636 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MEN1 O00255 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20945353 0.87 ALDH1A1 (0.44) ALDH1A1NPC1RAB9ACASP3SENP8
SCHEMBL28107475 0.82 HPGD (0.40) ALDH1A1NPC1RAB9ACASP3SENP8
SCHEMBL27694609 0.80 ALDH1A1 (0.37) ALDH1A1CYP1A2CYP2C19KDM4ECYP3A4
SCHEMBL442437 0.79 ALDH1A1 (0.52) ALDH1A1NPC1RAB9ACASP3SENP8
SCHEMBL18945561 0.79 FFAR1 (0.46) ALDH1A1NPC1RAB9AFFAR1CYP1A2
SCHEMBL556901 0.78 TAAR1 (0.40) MAPTHPGDSMN1; SMN2
SCHEMBL4618290 0.78 ALDH1A1 (0.56) ALDH1A1NPC1RAB9ACASP3SENP8
SCHEMBL17941764 0.78 ALDH1A1 (0.50) ALDH1A1NPC1RAB9ACASP3SENP8
SCHEMBL5255523 0.76 ALDH1A1 (0.65) ALDH1A1RAB9ACYP1A2CYP2C19KDM4E
SCHEMBL3623135 0.76 KDM4E (0.43) ALDH1A1NPC1RAB9ATDP1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3215509-A1 SUBSTITUTED PYRROLO[1,2-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS Lysosomal Therapeutics Inc. (US) 2017-09-13 EP disclosed
WO-2016073891-A1 SUBSTITUTED PYRROLO[1,2-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS LYSOSOMAL THERAPEUTICS INC. (US) 2016-05-12 WO disclosed